Literature DB >> 6213725

Effect of beta-lactam antibiotics of the resistance of the digestive tract of mice to colonization.

D van der Waaij, H Hofstra, N Wiegersma.   

Abstract

Four broad-spectrum antibiotics-azlocillin, mezlocillin, cefuroxime, and moxalactam - were injected subcutaneously into mice twice a day. The animals divided into treatment groups for each antibiotic and then into subgroups, each subgroup receiving a different dose of antibiotic. The effect of treatment on the resistance of the digestive tract to colonization and the effect of treatment on endogenous gram-negative and intestinal streptococcal flora was studied: resistance to colonization decreased during treatment with approximately 0.9 mg of antibiotic per mouse per day. During treatment with this dose or a higher dose, Escherichia coli or a strain of Enterobacter resistant to the antibiotic being used grew to significantly higher numbers per gram of feces than in the control groups. The resistance of the digestive tract to colonization in mice decreases during systemic treatment with all four antibiotics at or above certain dose levels, a result also likely to occur in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213725     DOI: 10.1093/infdis/146.3.417

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

Review 1.  The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.

Authors:  D van der Waaij
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

2.  Effect of imipenem-cilastatin therapy on fecal flora.

Authors:  C J Welkon; S S Long; P H Gilligan
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

Review 3.  Host impairments in patients with neoplastic diseases.

Authors:  J Peter Donnelly; Nicole M A Blijlevens; Walter J F M van der Velden
Journal:  Cancer Treat Res       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.